Dr. Carling is the section chief of Endocrine Surgery and Associate Professor of Surgery at Yale University School of Medicine. He serves as the Director of Endocrine Cancer, Smilow Cancer Hospital, the Yale Endocrine Neoplasia Laboratory, and Endocrine Surgery Fellowship. He is a highest-volume surgeon and his clinical interests are surgery of the thyroid, parathyroid, and adrenal glands, including minimally invasive laparoscopic and retroperitoneoscopic surgical techniques. Dr. Carling and the Yale team performed the first "scarless" transoral endoscopic thyroidectomies and parathyroidectomies (vestibular approach; TOETVA, TOEPVA) in the world, outside of Asia. His research interests involve molecular and tumor genetics of endocrine tumors, including inherited endocrine tumor susceptibility syndromes. Dr. Carling has published in the most prestigious medical journals, including Science, Nature Medicine, Nature Genetics, New England Journal of Medicine, PNAS, and Human Molecular Genetics. According to Google Scholar calculations of scientific impact, Dr. Carling ranks within the highest-quality elite of the world. As a physician-leader, he has implemented improved endocrine medical and surgical care, as well as enhanced cancer prevention and genetics programs across the Yale New Haven Health Systems, a 1,541 bed system, one of the largest in the country.
For international patients, who wish to obtain a consultation with Dr. Carling, please call +1-203-737-2036.
He obtained his MD and PhD from Uppsala University, Sweden. He was a postdoctoral fellow in Cancer Genetics at The Burnham Institute, La Jolla, CA. He completed his training in both General Surgery and Endocrine Surgery at Yale New Haven Hospital.
- Thyroid Diseases
Accepts new patients? Yes
Patient Type: Adult; Child
Referrals: From patients or physicians
Patient Care Organizations
Genetics Consultation Service
Surgery, General AB of Surgery (2008)
|Diseases of the Endocrine System||Kinetics of mid-molecule parathyroid hormone (PTH)|
|Thyroid||Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma|